Study of chromosomal region 5p13.1 in Crohn's disease, ulcerative colitis, and rheumatoid arthritis

Human Immunology

Volumn 71, Issue 8, 2010, Pages 826-828

  Perdigones, Nieves ^a   Martín, Ezequiel ^b   Robledo, Gema ^b   Lamas, José Ramón ^a   Taxonera, Carlos ^a   Díaz Rubio, Manuel ^a   de la Concha, Emilio G ^a   López Nevot, Miguel Angel ^c   García, Antonio ^c   Gómez García, María ^c   Fernández Gutiérrez, Benjamín ^a   Martín, Javier ^b   Urcelay, Elena ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^b INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

Author keywords

5p13.1; Crohn's disease; Rheumatoid arthritis; Ulcerative colitis

Indexed keywords

COLLAGEN; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E2; PROSTAGLANDIN EP4 RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; CAUCASIAN; CHROMOSOME 5P; CONTROLLED STUDY; CROHN DISEASE; DISEASE SEVERITY; FEMALE; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RECEPTOR GENE; RHEUMATOID ARTHRITIS; SINGLE NUCLEOTIDE POLYMORPHISM; ULCERATIVE COLITIS;

ARTHRITIS, RHEUMATOID; CHI-SQUARE DISTRIBUTION; CHROMOSOMES, HUMAN, PAIR 5; COLITIS, ULCERATIVE; CROHN DISEASE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; RECEPTORS, PROSTAGLANDIN E;

EID: 77954761015     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2010.05.010     Document Type: Article

References (22)

1. Barrett J.C., Hansoul S., Nicolae D.L., Cho J.H., Duerr R.H., Rioux J.D., et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet 2008, 40:955-962.
2. Libioulle C., Louis E., Hansoul S., Sandor C., Farnir F., Franchimont D., et al. Novel Crohn disease locus identified by genome-wide association maps to a gene desert on 5p13.1 and modulates expression of PTGER4. PLoS Genet 2007, 3:e58.
3. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007, 447:661-678. Wellcome Trust, Case Control Consortium.
4. Fisher S.A., Tremelling M., Anderson C.A., Gwilliam R., Bumpstead S., Prescott N.J., et al. Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn's disease. Nat Genet 2008, 40:710-712.
5. Franke A., Balschun T., Karlsen T.H., Sventoraityte J., Nikolaus S., Mayr G., et al. Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility. Nat Genet 2008, 40:1319-1323.
6. Kabashima K., Saji T., Murata T., Nagamachi M., Matsuoka T., Segi E., et al. The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut. J Clin Invest 2002, 109:883-893.
7. McCoy J.M., Wicks J.R., Audoly L.P. The role of prostaglandin E2 receptors in the pathogenesis of rheumatoid arthritis. J Clin Invest 2002, 110:651-658.
8. Honda T., Segi-Nishida E., Miyachi Y., Narumiya S. Prostacyclin-IP signaling and prostaglandin E2-EP2/EP4 signaling both mediate joint inflammation in mouse collagen-induced arthritis. J Exp Med 2006, 203:325-335.
9. Goodwin J.S. Mechanism of action of nonsteroidal anti-inflammatory agents. Postgrad Med 1983, Spec No:23-31.
10. Martel-Pelletier J., Lajeunesse D., Reboul P., Pelletier J.P. Therapeutic role of dual inhibitors of 5-LOX and COX, selective and non-selective non-steroidal anti-inflammatory drugs. Ann Rheum Dis 2003, 62:501-509.
11. Sheibanie A.F., Khayrullina T., Safadi F.F., Ganea D. Prostaglandin E2 exacerbates collagen-induced arthritis in mice through the inflammatory interleukin-23/interleukin-17 axis. Arthritis Rheum 2007, 56:2608-2619.
12. Mathieu M.C., Lord-Dufour S., Bernier V., Boie Y., Burch J.D., Clark P., et al. Mutual antagonistic relationship between prostaglandin E(2) and IFN-gamma: Implications for rheumatoid arthritis. Eur J Immunol 2008, 38:1900-1912.
13. Lennard-Jones J.E. Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl 1989, 170:2-6. discussion 16-9.
14. Oliver J., Marquez A., Gomez-Garcia M., Martinez A., Mendoza J.L., Vilchez J.R., et al. Association of the macrophage migration inhibitory factor gene polymorphisms with inflammatory bowel disease. Gut 2007, 56:150-151.
15. Arnett F.C., Edworthy S.M., Bloch D.A., McShane D.J., Fries J.F., Cooper N.S., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988, 31:315-324.
16. Ioannidis J.P., Boffetta P., Little J., O'Brien T.R., Uitterlinden A.G., Vineis P., et al. Assessment of cumulative evidence on genetic associations: Interim guidelines. Int J Epidemiol 2008, 37:120-132.
17. Yamazaki K., Onouchi Y., Takazoe M., Kubo M., Nakamura Y., Hata A. Association analysis of genetic variants in IL23R, ATG16L1 and 5p13.1 loci with Crohn's disease in Japanese patients. J Hum Genet 2007, 52:575-583.
18. Cheon H., Rho Y.H., Choi S.J., Lee Y.H., Song G.G., Sohn J., et al. Prostaglandin E2 augments IL-10 signaling and function. J Immunol 2006, 177:1092-1100.
19. Sheibanie A.F., Tadmori I., Jing H., Vassiliou E., Ganea D. Prostaglandin E2 induces IL-23 production in bone marrow-derived dendritic cells. FASEB J 2004, 18:1318-1320.
20. Huizinga T.W., Keijsers V., Yanni G., Hall M., Ramage W., Lanchbury J., et al. Are differences in interleukin 10 production associated with joint damage?. Rheumatol Oxf 2000, 39:1180-1188.
21. + T cells and promotes osteoclastogenesis in an autoimmune arthritis model. J Immunol 2008, 181:1507-1518.
22. Raychaudhuri S., Remmers E.F., Lee A.T., Hackett R., Guiducci C., Burtt N.P., et al. Common variants at CD40 and other loci confer risk of rheumatoid arthritis. Nat Genet 2008, 40:1216-1223.